Document is current
Any future updates will be listed below
-
Authors
Frost, Freddy
Rivera-Caravaca, José Miguel
Lip, Gregory Y. H.
-
Funding
Funding for this research was provided by:
Bristol Myers Squibb– Pfizer alliance (CV185-805)
- License Information
-
More Information
Article History
Accepted: 27 March 2025
First Online: 5 April 2025
Declarations
:
: JMR-C: Consultant for Idorsia Pharmaceuticals LTD. FF: Speaker for Chiesi, Vertex Pharmaceuticals and Astrazeneca. GYHL: Consultant and speaker for BMS/Pfizer, Boehringer Ingelheim, Anthos and Daiichi-Sankyo. No fees are received personally. GYHL is a National Institute for Health and Care Research (NIHR) Senior Investigator and co-principal investigator of the AFFIRMO project on multimorbidity in AF, which has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 899871.
